KRISTY KEATING: Open Payments
NPI 1326270059 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 54 payments from 12 companies in 2025. Trend: 2023 $1,434 · 2024 $1,119 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $267 |
| PFIZER INC. | 12 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $153 |
| Kestra Medical Technology Services, Inc. | 4 | $81 |
| Amgen Inc. | 5 | $71 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| BridgeBio Pharma, Inc. | 2 | $44 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: LEQVIO, VYNDAQEL, LOKELMA, Assure WCD, REPATHA, OPSUMIT, AMVUTTRA, FARXIGA.
Industry payments across AZ — which companies pay providers there.
